Our bodies are marvels of biological engineering. Inside every cell lies a blueprint: our DNA. This blueprint contains instructions for everything our bodies do. But, sometimes, these instructions have errors. We call these errors genetic disorders.

For years, doctors have treated the symptoms of genetic disorders. It's been like putting a bandaid on a broken bone. But what if we could fix the blueprint itself? That's the promise of gene therapy. Read on to find out more.

Understanding Our Genetic Blueprint

DNA is the foundation of life. It's a long molecule that contains all the instructions our body needs. These instructions are divided into genes and each gene tells our cells how to make a specific protein.¹

Proteins are the workhorses of our cells. They perform countless tasks essential for life. When a gene has an error, it can't make the right protein. This in turn leads to problems in the body known as genetic disorders.²

The human genome contains approximately 20,000 to 25,000 genes. These genes are spread across 23 pairs of chromosomes. Each gene can range in size from a few hundred DNA bases to more than 2 million bases.³

Types of Genetic Disorders

There are a few different ways our body's instruction manual can go wrong:⁴

• Single-gene disorders: In these conditions, only one gene has an error. Sickle cell anemia is an example. It affects about 8 million people worldwide.⁵
• Chromosomal disorders: Entire chunks of DNA are affected. Down syndrome falls into this category, occurring in about 1 in 700 babies born.⁶
• Multifactorial disorders: Multiple genes and environmental factors play a role. Think heart disease or diabetes. Heart disease is the leading cause of death worldwide, causing roughly one-third of all deaths globally.⁷

Genetic disorders can range from mild to life-threatening. Until recently, doctors could only treat the symptoms. But gene therapy aims to change that.

Gene Therapy: Editing the Blueprint

Gene therapy is a revolutionary approach to treating genetic disorders. It targets the root cause – the faulty genes themselves. There are several ways to do this:

• Gene replacement: Scientists insert a healthy copy of the gene into the cell⁸
• Gene silencing: They turn off a gene that's causing problems⁹
• Gene addition: They introduce a new gene to help fight a disease¹⁰

It's like having a genetic spell-check for our DNA.

The concept of gene therapy isn't new. Scientists first proposed it in the 1970s. However, it took decades of research before the first successful treatments emerged. The field has accelerated rapidly in recent years with the FDA approving the first gene therapy for an inherited disease in 2017.¹¹

Delivering the Genetic Fix

Getting new genes into our cells is tricky. Scientists use something called a vector and, often, this vector is a virus. This virus is then modified to be harmless. It's now a delivery truck for therapeutic genes.¹²

There are two main delivery methods:

• In vivo therapy: The vector goes directly into the body. This method is often used for disorders affecting large organs or systems¹³
• Ex vivo therapy: Doctors remove cells, treat them in the lab, and return them to the body. This approach works well for blood disorders and some immune system problems¹³

Both methods have their uses. The choice depends on the specific disorder and treatment goals.

Researchers are constantly developing new vectors. Adeno-associated viruses (AAVs) are popular due to their safety profile and ability to infect both dividing and non-dividing cells. Lentiviruses, derived from HIV, are also used – especially for ex vivo therapies.¹²

Real-World Gene Therapy Successes

Gene therapy isn't just a theory. It's already changing lives:

• Luxturna: This therapy treats a rare form of inherited blindness called Leber congenital amaurosis.^14,15 It gives patients the gift of sight. In clinical trials, 93% of participants were assumed to be successfully treated.¹⁶
• Zolgensma: It treats spinal muscular atrophy (SMA) in infants. Children who once faced certain death now have a chance at life.^17,18 In a key clinical trial, all 15 patients treated with Zolgensma were alive at 24 months of age, compared to only 8% survival in historical cohorts.¹⁹
• Strimvelis: This therapy tackles "bubble boy" disease, or ADA-SCID. It gives patients a functioning immune system.^20,21 The therapy has a 100% survival rate at three years post-treatment.²²
• Hemgenix: Approved in 2022, this therapy treats Hemophilia B. In clinical trials, it reduced the annual rate of bleeding by 54% and nearly eliminated the need for factor IX replacement therapy.²³

These successes are just the beginning. Scientists are working on treatments for many other disorders. As of 2023, there are over 3900 gene therapy clinical trials underway worldwide.²⁴

Challenges in Gene Therapy

Despite its promise, gene therapy faces hurdles:

• Safety: The body might attack the vector, causing inflammation. In severe cases, this can lead to organ failure or death. A tragic example occurred in 1999 when a teenager died during a gene therapy trial due to a severe immune reaction.²⁵
• Precision: Getting the new gene to the right cells is gruelling. Off-target goods can lead to unintended consequences. Scientists are developing more precise delivery styles and gene-editing tools to address this problem.²⁶
• Ethical considerations: While physical gene remedy (which affects only the patient) is generally accepted, germline gene remedy (which affects unborn generations) remains controversial.²⁷ There are enterprises about "playing God" with mortal genes and the possibility of "developer babies", where gene editing could be used to enhance traits like intelligence.²⁸
• Cost: Current treatments can cost millions of dollars. Zolgensma, for example, costs $2.1 million per patient.²⁹ This high cost limits access and puts a strain on healthcare systems.
• Durability: Some gene therapies may not provide lifelong effects. Researchers are working on ways to make treatment more permanent.

These challenges are significant. But scientists are working hard to overcome them. Each year brings new breakthroughs and refinements to gene therapy techniques.

The Future of Gene Therapy

The future of gene remedy looks bright. New technologies like CRISPR are making gene editing more precise. CRISPR, discovered in 2012, allows scientists to edit DNA with unparalleled delicacy. It's formerly been used in clinical trials for conditions like sickle cell disease and certain cancers.³⁰

Scientists are exploring better delivery methods. Some are investigating the use of nanoparticles instead of viruses. Others are working on ways to make the treatments more affordable. For example, researchers are developing universal donor cells that could reduce the cost of personalised therapies.³¹

One exciting possibility is personalised medicine. Doctors could tailor treatments to a patient's specific genetic makeup. This could lead to more effective treatments with fewer side-effects. The growth of genetic testing is paving the way for this approach. As of 2023, over 26 million people have taken direct-to-consumer genetic tests.³²

Gene therapy might also expand beyond inherited disorders. Researchers are exploring its use in treating acquired conditions like heart disease, Alzheimer's disease – and even aging itself. A study in mice in 2019 successfully used gene therapy to reverse age-related cognitive decline.³³

A New Chapter in Medicine

Gene therapy represents a fundamental shift in the paradigm of medicine. It offers the possibility of curing diseases once thought incurable. Children who faced lifelong disability are now running and playing. People who were going blind can now see.

We're at the beginning of a new era in medicine. Our genes are no longer our destiny. They're a blueprint we can edit and improve. Indeed the global gene therapy market, valued at $1.3 billion in 2019, is projected to reach $10 billion by 2026.³⁴

The road ahead has its challenges. Ensuring equitable access to these therapies will be crucial. We must also grapple with ethical questions about the limits of genetic manipulation. International cooperation will be key to addressing these issues.

But the potential rewards are enormous. Gene therapy could transform millions of lives. It might even lead to treatments for non-genetic diseases like cancer. In 2017, the FDA approved the first gene therapy for certain types of leukemia and lymphoma.

In the future, fixing a faulty gene might be as routine as getting a vaccine. The possibilities are as vast as the human genome itself. We're not just treating symptoms anymore. We're rewriting the very code of life itself.

As we look to the future, it's clear that gene therapy will play an increasingly important role in healthcare. It's not a silver bullet for all medical problems, but it offers hope where once there was none. With continued research and ethical oversight, gene therapy promises to revolutionise medicine in the 21st century and beyond.

Summary

Gene therapy transforms the treatment of genetic disorders by targeting faulty genes directly. It replaces, inactivates, or introduces genes to correct genetic errors. This approach offers hope for diseases like cystic fibrosis and spinal muscular atrophy.

Scientists use modified viruses to deliver therapeutic genes into cells. Successful treatments like Luxturna (restoring vision in a rare blindness disorder) and Zolgensma (treating infants with spinal muscular atrophy) demonstrate the potential of gene therapy. 

Challenges persist, including safety concerns, delivery precision, and high costs. Ethical debates also surround gene editing technologies. Despite these hurdles, gene therapy is advancing rapidly. It promises personalised treatments and potential cures for previously untreatable genetic conditions.